Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03517397 · ClinicalTrials.gov registry record · NA

Mobile Contingency Management for Smoking Cessation (R01 Supplement) (PrevailGO)

A NA study of Smoking Cessation, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03517397: Completed NA study of Smoking Cessation, sponsored by University of Oklahoma.

NCT03517397 is a NA study of Smoking Cessation that has completed, run by University of Oklahoma. The registered enrollment target is 20 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03517397, a NA study of Smoking Cessation, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Smoking prevalence rates are disproportionately high among individuals living below the poverty threshold, those living in rural areas, and Oklahomans. Nearly 1.3 million Oklahomans live in rural areas and the prevalence of poverty is elevated relative to the U.S. Our preliminary work has indicated that offering small escalating financial incentives for smoking abstinence (i.e., Contingency Management \[CM\]) dramatically increases short-term cessation rates among socioeconomically disadvantaged smokers when incentives are included as an adjunct to clinic-based smoking cessation treatment. However, other approaches are needed for socioeconomically disadvantaged individuals who are unable to attend clinic visits due to rural residence or other limitations. Internet and mobile phone-based CM approaches have been developed to reduce or eliminate the need for in-person visits. The goal of the current project is to improve upon existing mobile CM approaches by fully automating the process to make financial incentives interventions for smoking cessation feasible and accessible to individuals across the state. The aims of the proposed project are to 1) develop a fully automated, mobile phone-based CM approach to remotely verify smoking abstinence, confirm participant identity, and deliver financial incentives for smoking cessation, and 2) evaluate the feasibility and preliminary effectiveness of using fully automated mobile CM as an adjunct to telephone counseling and nicotine replacement therapy among 20 socioeconomically disadvantaged adults. The current project extends the scope of the parent study by increasing the reach of the CM approach to socioeconomically disadvantaged individuals who may be unable to attend in-person visits.

Primary Outcome

Self-reported abstinence over the past 7 days in conjunction with a carbon monoxide value \< 6 ppm

Conditions Studied

Interventions

  • BEHAVIORAL Mobile Contingency Management

Study Locations (1)

Oklahoma

  • The University of Oklahoma Health Sciences Center, Tobacco Treatment Research Program - Oklahoma City

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-08-15
Est. Completion 2019-05-15
Phase NA
University of Oklahoma

358 total trials

What the finished NCT03517397 record still lists

NCT03517397 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Mobile Contingency Management is the first listed.

NCT03517397 reports a single indexed study location in Oklahoma.

Frequently Asked Questions

What is clinical trial NCT03517397 about?

NCT03517397 is a clinical study titled "Mobile Contingency Management for Smoking Cessation (R01 Supplement) (PrevailGO)". Smoking prevalence rates are disproportionately high among individuals living below the poverty threshold, those living in rural areas, and Oklahomans. Nearly 1.3 million Oklahomans live in rural areas and the prevalence of poverty is elevated relative to the U.S. Our preliminary work has indicated ...

What is the current status of trial NCT03517397?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-08-15. Estimated completion is 2019-05-15.

What conditions does trial NCT03517397 study?

This clinical trial studies the following conditions: Smoking Cessation.

What interventions are being tested in trial NCT03517397?

The interventions under investigation include: Mobile Contingency Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT03517397?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03517397 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03517397's enrollment target sits among peer trials

20 173rd of 188 higher than 10 of 188 other Smoking Cessation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03517397, the US trial registry maintained by the National Library of Medicine. NCT03517397 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.